Schedule 13G ownership disclosure

CALADRIUS BIOSCIENCES ORD

Security class unavailable · CUSIP: 128058203

Event date: 2016-09-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
635,593
Percent of class
9.7038%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-145923
Form type
SC 13G
Filer
LISATA THERAPEUTICS, INC.
CIK
CIK 320017
Filed
Sep 21, 2016
Reporting period
Sep 14, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub